Nanomedicine Nanotechnology Biology and Medicine · 2014 · 27 citations · 34 references
MedicineOncologyPharmacologyChemotherapyDrug DeliveryMolecular OncologyCancer BiotechnologyCancer NanomedicineNanomedicinePancreatic CancerRna InterferenceSmall Interfering Rna DeliveryChemical Modification Of Small Interfering RnaMolecular Drug ResistancePancreatic Cancer PharmacotherapyRna Interference TherapeuticsSmall Interfering Rna (Sirna) ChemistrySmall Interfering Rna (Sirna) PathwaysTherapeutic Ribonucleic Acid InterferenceTherapeutic Small Interfering Rna
Gemcitabine is currently the standard therapy for pancreatic cancer. However, growing concerns over gemcitabine resistance mean that new combinatory therapies are required to prevent loss of efficacy with prolonged treatment. Here, we suggest that this could be achieved through co-administration of RNA interference agents targeting the ubiquitin ligase ITCH. Stable anti-ITCH siRNA and shRNA dendriplexes with a desirable safety profile were prepared using generation 3 poly(propylenimine) dendrimers (DAB-Am16). The complexes were efficiently taken up by human pancreatic cancer cells and produced a 40-60% decrease in ITCH RNA and protein expression in vitro (si/shRNA) and in a xenograft model of pancreatic cancer (shRNA). When co-administered with gemcitabine (100 mg/kg/week) at a subtherapeutic dose, treatment with ITCH-shRNA (3x 50 mg/week) was able to fully suppress tumour growth for 17 days, suggesting that downregulation of ITCH mediated by DAB-Am16/shRNA sensitizes pancreatic cancer to gemcitabine in an efficient and specific manner. FROM THE CLINICAL EDITOR: Gemcitabine delivery to pancreatic cancer often results in the common problem of drug resistance. This team overcame the problem through co-administration of siRNA and shRNA dendriplexes targeting the ubiquitin ligase ITCH.
34
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Andrew Fire, Siqun Xu, Mary K. Montgomery et al. · Nature · 1998 · 15.3K citations · Full text
Martin Lundqvist, Johannes Stigler, Giuliano Elia et al. · Proceedings of the National Academy of Sciences · 2008 · 3K citations · Full text
Guidelines for the welfare and use of animals in cancer research
Paul Workman, Eric O. Aboagye, Frances R. Balkwill et al. · British Journal of Cancer · 2010 · 1.4K citations · Full text
Medicine, Animal Sciences, Oncology +17
Time Evolution of the Nanoparticle Protein Corona
Eudald Casals, Tobias Pfaller, Albert Duschl et al. · ACS Nano · 2010 · 1.2K citations